UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) August 15, 2016

iGambit Inc.

(Exact name of registrant as specified in its charter)

Delaware

000-53862

(State or other jurisdiction

(Commission File Number)

(IRS Employer

of incorporation)

Identification No.)

1050 W. Jericho Turnpike, Suite A

11787

Smithtown, New York

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (631) 670-6777

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of

the registrant under any of the following provisions (see General Instruction A.2. below):

¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




ITEM 8.01       Other Events

On   August   15,   2016   iGambit   Inc.    (the   ‘Company”),   entered   into   a   Letter   of   Intent   (the   “LOI”)

with   EncounterCare   Solutions   Inc.   (ECSL),   an   Energy   and   Healthcare   company that   operates   its

business   through   three   divisions,   the   Energy   Division,   the   Healthcare   Technology   Division   and

the Healthcare Services Division.

Pursuant    to    the    LOI,    at    closing,    iGambit    Inc.    (“iGambit”)    will    acquire    certain    assets    of

EncounterCare   Solutions   Inc.   (EncounterCare),   including   its   CyberCare   Health   Network

Division   and   will   assume   certain   specifically   identified   operating   liabilities   of   EncounterCare.

Payment   for   the   acquisition   will   be   made   in   the   form   of   sixty   million   (60,000,000)   shares   of

iGambit common stock.

The LOI has certain binding and non-binding obligations, including the acquisition consideration

which   is   subject   to   adjustment   and   the   transaction   is   subject   to   various   conditions   to   closing,

including   satisfactory   completion   of   due   diligence,   approval   of   the   Company’s   shareholders,   if

required,    and    definitive    documentation.     There    can    be    no    assurance    that    the    transactions

contemplated   by   the   LOI   will   be   consummated.   The   LOI   and   this   Current   Report   on   Form   8-K

do not   constitute an offer to buy, or solicitation of an offer to sell, any securities of the Company

and  no  offer  or  sale  of  such  securities  will  be  made  in  any   jurisdiction  where  it  would  be

unlawful to do so.

ITEM 7.01       Regulation FD Disclosure

On August 15, 2016, the Company issued a press release announcing the LOI, a copy of which is

attached hereto as Exhibit 99.1.

ITEM 9.01 Financial Statements and Exhibits

(d)      Exhibits

The following Exhibits are filed as part of this Report:

99.1     Press Release related to Announcement of Letter of Intent dated August 15, 2016.

Forward–Looking Statements

This    report    regarding    the    Company’s    business    and    operations    includes    “forward-looking

statements”   within   the   meaning   of   the   Private   Securities   Litigation   Reform   Act   of   1996.   Such

statements   consist   of any statement   other than   a   recitation   of historical   fact   and   can   be   identified

by   the   use   of   forward-looking   terminology   such   as   “may,”   “expect,”   “anticipate,”   “intend”   or

“estimate”   or   the   negative   thereof   or   other   variations   thereof   or   comparable   terminology.   The

reader is cautioned that all forward-looking statements are speculative, and there are certain risks

and uncertainties   that   could   cause   actual   events   or results   to   differ from those   referred   to   in   such

forward-looking statements.   This   disclosure   highlights   some   of   the   important   risks   regarding the

Company’s   business.   The   primary   risk   attributable   to   the   Company   is   its   ability   to   attract   fresh

and   continued   capital   to   execute   its   comprehensive   business   strategy.   There   may   be   additional




risks  associated  with   the   integration   of   businesses   following   an   acquisition,   concentration   of

revenue    from    one    source,    competitors    with    broader    product    lines    and    greater    resources,

emergence   into   new   markets,   the   termination   of   any   of   the   Company’s   significant   contracts   or

partnerships,   the   Company’s   ability   to   comply   with   its   senior   debt   agreements,   the   Company’s

inability   to   maintain   working   capital   requirements   to   fund   future   operations,   or   the   Company’s

ability   to   attract   and   retain   highly   qualified   management,   technical   and   sales   personnel, and   the

other factors identified by us from time to time in the Company’s filings with the SEC. However,

the    risks    included    should    not    be    assumed    to    be    the    only    things    that    could    affect    future

performance.   We   may   also   be   subject   to   disruptions,   delays   in   collections,   or   facilities   closures

caused by potential or actual acts of terrorism or government security concerns.

All   forward-looking   statements   included   in   this   document   are   made   as   of   the   date   hereof,   based

on   information   available   to   us   as   of   the   date   thereof,   and   we   assume   no   obligation   to   update   any

forward-looking statements.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant caused this

report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date:  August 15, 2016

iGambit Inc.

By:

/s/  Elisa Luqman

Elisa Luqman

Chief Financial Office r



Exhibit Index

Exhibit No.      Description

99.1     Press Release related to Announcement of Letter of Intent dated August 15, 2016.

1